282 related articles for article (PubMed ID: 35562515)
41. SLITRK6 promotes the progression of lung adenocarcinoma by regulating PI3K/AKT/mTOR signaling and Warburg effect.
Yu F; Zhao X; Li M; Meng M
Apoptosis; 2023 Aug; 28(7-8):1216-1225. PubMed ID: 37219677
[TBL] [Abstract][Full Text] [Related]
42. FAM83B promotes the invasion of primary lung adenocarcinoma via PI3K/AKT/NF-κB pathway.
Zhang J; Wang J; Yue K; Li P; Shen W; Qiao X; Wang Y; Wu X
BMC Pulm Med; 2023 Jan; 23(1):32. PubMed ID: 36690987
[TBL] [Abstract][Full Text] [Related]
43. Nucleophosmin promotes lung adenocarcinoma cell proliferation, migration and invasion by activating the EGFR/MAPK signaling pathway.
Li M; Wu R; Zhu D; Wang L; Liu S; Wang R; Deng C; Zhang S; Chen M; Lu R; Zhu H; Mo M; Luo Z
Oncol Rep; 2023 Jun; 49(6):. PubMed ID: 37165929
[TBL] [Abstract][Full Text] [Related]
44. GALNT2 promotes cell proliferation, migration, and invasion by activating the Notch/Hes1-PTEN-PI3K/Akt signaling pathway in lung adenocarcinoma.
Wang W; Sun R; Zeng L; Chen Y; Zhang N; Cao S; Deng S; Meng X; Yang S
Life Sci; 2021 Jul; 276():119439. PubMed ID: 33785338
[TBL] [Abstract][Full Text] [Related]
45. STRIP2, a member of the striatin-interacting phosphatase and kinase complex, is implicated in lung adenocarcinoma cell growth and migration.
Qiu LM; Sun YH; Chen TT; Chen JJ; Ma HT
FEBS Open Bio; 2020 Mar; 10(3):351-361. PubMed ID: 31901223
[TBL] [Abstract][Full Text] [Related]
46. MiR-340-3p-HUS1 axis suppresses proliferation and migration in lung adenocarcinoma cells.
Ren K; Yu Y; Wang X; Liu H; Zhao J
Life Sci; 2021 Jun; 274():119330. PubMed ID: 33711383
[TBL] [Abstract][Full Text] [Related]
47. UBE4B promotes the development of lung adenocarcinoma by enhancing proliferation, migration and glycolysis via PP2A/AKT signaling.
Wu S; Xie L; Cheng S; Fan Z; Sang H; Li Q
Pathol Res Pract; 2022 Apr; 232():153762. PubMed ID: 35220170
[TBL] [Abstract][Full Text] [Related]
48. Identification of LBX2 as a novel causal gene of lung adenocarcinoma.
Hu J; Bai Y; Zhang Q; Li M; Yin R; Xu L
Thorac Cancer; 2020 Aug; 11(8):2137-2145. PubMed ID: 32567804
[TBL] [Abstract][Full Text] [Related]
49. Hypomethylation-associated LINC00987 downregulation induced lung adenocarcinoma progression by inhibiting the phosphorylation-mediated degradation of SND1.
Lai Q; Wan Y; Zhang Y; Huang Y; Tang Q; Chen M; Li Q; Ma K; Xiao P; Luo C; Zhuang X
Mol Carcinog; 2024 Jul; 63(7):1260-1274. PubMed ID: 38607240
[TBL] [Abstract][Full Text] [Related]
50. PKMYT1 inhibits lung adenocarcinoma progression by abrogating AKT1 activity.
Wang S; Liu X; Zhou T; Li J; Lin Y; Zhou A; Huang J; Zhao J; Cai J; Cai X; Huang Y; Li X
Cell Oncol (Dordr); 2023 Feb; 46(1):195-209. PubMed ID: 36350496
[TBL] [Abstract][Full Text] [Related]
51. Actin-like protein 8 promotes cell proliferation, colony-formation, proangiogenesis, migration and invasion in lung adenocarcinoma cells.
Ma S; Wang X; Zhang Z; Liu D
Thorac Cancer; 2020 Mar; 11(3):526-536. PubMed ID: 31962007
[TBL] [Abstract][Full Text] [Related]
52. The miR-4732-5p/XPR1 axis suppresses the invasion, metastasis, and epithelial-mesenchymal transition of lung adenocarcinoma
Hu Y; Bai J; Zhou D; Zhang L; Chen X; Chen L; Liu Y; Zhang B; Li H; Yin C
Mol Omics; 2022 Jun; 18(5):417-429. PubMed ID: 35388387
[TBL] [Abstract][Full Text] [Related]
53. Junctional adhesion molecule-like protein as a novel target for kaempferol to ameliorate lung adenocarcinoma.
Wu Q; Wang YB; Che XW; Wang H; Wang W
J Integr Med; 2023 May; 21(3):268-276. PubMed ID: 37069006
[TBL] [Abstract][Full Text] [Related]
54. UHMK1 promotes lung adenocarcinoma oncogenesis by regulating the PI3K/AKT/mTOR signaling pathway.
Li Y; Wang S; Jin K; Jin W; Si L; Zhang H; Tian H
Thorac Cancer; 2023 Apr; 14(12):1077-1088. PubMed ID: 36919755
[TBL] [Abstract][Full Text] [Related]
55. GBX2, as a tumor promoter in lung adenocarcinoma, enhances cells viability, invasion and migration by regulating the AKT/ERK signaling pathway.
Wang Y; Hui J; Li R; Fu Q; Yang P; Xiao Y; Hui J
J Gene Med; 2020 Feb; 22(2):e3147. PubMed ID: 31758726
[TBL] [Abstract][Full Text] [Related]
56. Inhibition of didscoidin domain receptor 1 reduces epithelial-mesenchymal transition and induce cell-cycle arrest and apoptosis in prostate cancer cell lines.
Azizi R; Salemi Z; Fallahian F; Aghaei M
J Cell Physiol; 2019 Nov; 234(11):19539-19552. PubMed ID: 30963567
[TBL] [Abstract][Full Text] [Related]
57. CHN1 promotes epithelial-mesenchymal transition via the Akt/GSK-3β/Snail pathway in cervical carcinoma.
Zhao H; Wang L; Wang S; Chen X; Liang M; Zhang X; Wang J; Xu X
J Transl Med; 2021 Jul; 19(1):295. PubMed ID: 34238315
[TBL] [Abstract][Full Text] [Related]
58. AKT2 drives cancer progression and is negatively modulated by miR-124 in human lung adenocarcinoma.
Liu T; Zhu J; Du W; Ning W; Zhang Y; Zeng Y; Liu Z; Huang JA
Respir Res; 2020 Sep; 21(1):227. PubMed ID: 32873299
[TBL] [Abstract][Full Text] [Related]
59. Discoidin domain receptor 1 is associated with poor prognosis of non-small cell lung cancer and promotes cell invasion via epithelial-to-mesenchymal transition.
Miao L; Zhu S; Wang Y; Li Y; Ding J; Dai J; Cai H; Zhang D; Song Y
Med Oncol; 2013; 30(3):626. PubMed ID: 23761027
[TBL] [Abstract][Full Text] [Related]
60. Overexpression of BCCIP predicts an unfavorable prognosis and promotes the proliferation and migration of lung adenocarcinoma.
Shi J; Lv X; Li W; Ming Z; Zeng L; Yuan J; Chen Y; Liu B; Yang S
Thorac Cancer; 2021 Sep; 12(17):2324-2338. PubMed ID: 34297484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
